SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-035423
Filing Date
2017-02-09
Accepted
2017-02-09 08:34:32
Documents
3
Period of Report
2017-02-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d348719d8k.htm 8-K 30651
2 EX-99.1 d348719dex991.htm EX-99.1 9932
3 GRAPHIC g348719g01l04.jpg GRAPHIC 3812
  Complete submission text file 0001193125-17-035423.txt   47217
Mailing Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451
Business Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 17584705
SIC: 2834 Pharmaceutical Preparations